News

DSNTV: Chasing — and engaging — today’s elusive consumer

BY DSN STAFF

 

Retailers and suppliers need to work harder to find creative ways to better engage today’s “elusive” consumer and motivate her to want to make a trip to the store, Lisa Paley, chief customer officer for Pfizer Consumer Healthcare, told Drug Store News for the latest edition of DSNTV Executive Viewpoint video interview series. 
 
“The consumer is a little elusive right now,” Paley explained. “They’re in control, but they’re not as identifiable: they’re doing a lot [online] pre-shop before they come to the store; they’re buying online; they’re buying [in] brick and mortar, so they’re a little hard to track and a little harder to engage to want to make the trip into the store.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

GSK working toward Ebola vaccine by end of 2014

BY Michael Johnsen

LONDON — GlaxoSmithKline expects to have its Ebola vaccine available by year's end, CEO and executive director Andew Witty told analysts during the company's third-quarter conference call Wednesday. 
 
"Given the apparent health emergency, we are leaving no stone unturned in this project," he said. "And if all goes well, I fully expect GSK to be the first company in a position to make a vaccine available to health agencies and governments hopefully, toward the end of 2014."
 
Both GSK and Johnson & Johnson are working toward providing an Ebola vaccine sooner than later
 
Johnson & Johnson on Wednesday announced that it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program in development at its Janssen Pharmaceutical Companies. Janssen is targeting production of more than one million doses of the vaccine regimen in 2015, 250,000 of which are expected to be released for broad application in clinical trials by May 2015.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

DSN asks industry to shape #DSNIndustryIssues discussion

BY DSN STAFF

NEW YORK — Drug Store News has lined up a high-caliber roster of retail executives for the 16th annual DSN Industry Issues Summit conference, Dec. 3 at Manhattan’s historic New York Athletic Club.

And for the first time in the event’s history, DSN is issuing an open-call to the industry for discussion points.

The day-long event — which has emerged as an important day on chain pharmacy’s holiday industry week calendar — features exclusive retailer roundtable discussions around three critical areas of the business, including emerging new healthcare technologies, diabetes and chronic care and driving front-end growth.

HELP SHAPE THE DISCUSSION

Drug Store News has also announced a first in the 16-year history of the program — an open call to DrugStoreNews.com users for suggested topics and areas of discussion for our panelists. Comment below and tell us what issues and questions you want us to explore on Dec. 3. Our moderators will pick the best of the best to include in the discussion.

FOLLOW US ON TWITTER

Follow the discussion (@DrugStoreNews) live on Twitter using #DSNIndustryIssues.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

C.QUINN says:
Nov-11-2014 07:57 pm

Many retail pharmacy organizations are evaluating joining Patient Safety Organizations (PSOs) for the Federal legal protection they provide. We've seen large retailers successfully defend themselves in the court systems potentially avoiding massive fines and/or lawsuits. This is something that's been mandated in the acute care space for hospitals (above 50 beds) in 2017 - is this something your organization has looked at and/or considered?

C.QUINN says:
Nov-11-2014 07:53 pm

Given the increased govern mental regulations (mandatory reporting, collection of core measures etc) we are seeing in the acute care space many are anticipating a trickle-down effect to retail pharmacy and for similar types of information around adverse event data collection, HIPAA breaches, and so on to eventually become mandated in this space as well. Is this something leaders of retail pharmacy organizations are anticipating or preparing for? Do they have in-house systems that would be upto snuff to handle this?

swiden says:
Nov-11-2014 12:27 pm

Background: The J.D. Power 2014 U.S. Pharmacy Study, released September 18, 2014, demonstrates even the briefest intervention message from a healthcare professional can have a positive impact on patient behaviors. Question: Given workflow challenges, is there a role in pharmacist intervention models for a brief encounter with the patient that provides a generically scripted disease awareness or management message, along with printed branded patient education, resulting in a larger volume of interventions?

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?